Marker Therapeutics Inc (MRKR)

[GoIrish1776]

IMO, they changed the trial design, delaying the trial, crushing the SP and risking terrible dilution for one of three reasons:
1) they are naïve (5%)
2) they believe they have the goods in the active arm w the current process and believe the SP will take off with the release of data “Q1/Q2” (5%)
3) they knew the active data is bad based on the 6 lead in and currently dosed patients and they wanted to get out ahead of it with some kind of story rather than release bad data and getting totally crushed later (90%)

Said differently, we’re getting what we deserve in a way. The trial didn’t work. They are finding a way to salvage something but we’re paying or are about to pay a very bad price.

I had the thought not long ago that the prudent thing to do was raise $20m or so when the SP was under $1. I would have cursed them but it would have been prudent. There is no bottom now. Maybe some level of cash.